nach oben

Erschienen in:

13.12.2022 | Peeling | Leitlinien, Stellungnahmen und Empfehlungen

Makulaforamen und vitreomakuläre Traktion

S1-Leitlinie der Deutschen Ophthalmologischen Gesellschaft (DOG), der Retinologischen Gesellschaft (RG) und des Berufsverbands der Augenärzte Deutschlands (BVA). Version: 22. September 2022

verfasst von: Deutsche Ophthalmologische Gesellschaft e. V. (DOG), Retinologische Gesellschaft e. V. (RG), Berufsverband der Augenärzte Deutschlands e. V. (BVA)

Erschienen in: Die Ophthalmologie | Sonderheft 1/2023

Einloggen, um Zugang zu erhalten

Auszug

Hilfestellung bei einer sinnvollen Gestaltung der Diagnostik von 2 wichtigen Krankheitsgruppen und Hilfen bei der Auswahl möglicher Therapien. …

Nur mit Berechtigung zugänglich

Bartz-Schmidt KU, Bertram B, Bornfeld N, Bresgen M, Eter N, Feltgen N et al (2013) Current statement of the German ophthalmological society, the retina society and the professional association of German ophthalmologists for therapeutic intravitreal application of ocriplasmin (JETREA ®) in ophthalmology (May 2013). Klin Monbl Augenheilkd 230(6):629–634

Berufsverband der Augenärzte Deutschlands e. V. (BVA), Deutsche Ophthalmologische Gesellschaft (DOG), Retinologische Gesellschaft e. V. (RG) (2021) Statement of the professional association of German ophthalmologists (BVA), the German ophthalmological society (DOG) and the retinological society (RG) on the development, diagnostics and treatment of epiretinal gliosis : status october 2020. Ophthalmologe 118(2):121–138CrossRef

Berufsverband der Augenärzte Deutschlands e. V., Deutsche Ophthalmologische Gesellschaft, Retinologische Gesellschaft e. V. (2017) Quality assurance of optical coherence tomography for diagnostics of the fundus : positional statement of the BVA, DOG and RG. Ophthalmologe 114(7):617–624

Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA et al (2020) Idiopathic macular hole preferred practice pattern. Ophthalmology 127(2):P184–222CrossRef

Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA et al (2020) Idiopathic epiretinal membrane and vitreomacular traction preferred practice pattern. Ophthalmology 127(2):P145–83CrossRef

Gass JD (1995) Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol 119(6):752–759CrossRef

Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E et al (2013) The international vitreomacular traction study group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology 120(12):2611–2619CrossRef

Darian-Smith E, Howie AR, Allen PL, Vote BJ (2016) Tasmanian macular hole study: whole population-based incidence of full thickness macular hole. Clin Exp Ophthalmol 44(9):812–816CrossRef

McCannel CA, Ensminger JL, Diehl NN, Hodge DN (2009) Population-based incidence of macular holes. Ophthalmology 116(7):1366–1369CrossRef

10.

Schuster AKG, Kluck AK, Korb CA, Stoffelns B, Nickels S, Schulz A et al (2020) Characteristics and pathologies of the vitreo-macular interface-results from the Gutenberg Health Study. Acta Ophthalmol 98(3):e273–81CrossRef

11.

Meuer SM, Myers CE, Klein BEK, Swift MK, Huang Y, Gangaputra S et al (2015) The epidemiology of vitreoretinal interface abnormalities as detected by spectral-domain optical coherence tomography: the beaver dam eye study. Ophthalmology 122(4):787–795CrossRef

12.

Liesenborghs I, De Clerck EEB, Berendschot TTJM, Goezinne F, Schram MT, Henry RMA et al (2018) Prevalence of optical coherence tomography detected vitreomacular interface disorders: the Maastricht study. Acta Ophthalmol 96(7):729–736CrossRef

13.

Lindtjørn B, Krohn J, Austeng D, Fossen K, Varhaug P, Basit S et al (2019) Nonsupine positioning after macular hole surgery: a prospective multicenter study. Ophthalmol Retina 3(5):388–392CrossRef

14.

Sugiyama A, Imasawa M, Chiba T, Iijima H (2012) Reappraisal of spontaneous closure rate of idiopathic full-thickness macular holes. Open Ophthalmol J 6:73–74CrossRef

15.

Parravano M, Giansanti F, Eandi CM, Yap YC, Rizzo S, Virgili G (2015) Vitrectomy for idiopathic macular hole. Cochrane Database Syst Rev 5:CD9080

16.

Dugel PU, Tolentino M, Feiner L, Kozma P, Leroy A (2016) Results of the 2‑year ocriplasmin for treatment for symptomatic vitreomacular adhesion including macular hole (OASIS) randomized trial. Ophthalmology 123(10):2232–2247CrossRef

17.

Watzke RC, Allen L (1969) Subjective slitbeam sign for macular disease. Am J Ophthalmol 68(3):449–453CrossRef

18.

DeCroos FC, Toth CA, Folgar FA, Pakola S, Stinnett SS, Heydary CS et al (2012) Characterization of vitreoretinal interface disorders using OCT in the interventional phase 3 trials of ocriplasmin. Invest Ophthalmol Vis Sci 53(10):6504–6511CrossRef

19.

Tornambe PE, Poliner LS, Cohen RG (1998) Definition of macular hole surgery end points: elevated/open, flat/open, flat/closed. Retina 18(3):286–287CrossRef

20.

Kang SW, Ahn K, Ham DI (2003) Types of macular hole closure and their clinical implications. Br J Ophthalmol 87(8):1015–1019CrossRef

21.

Hubschman JP, Govetto A, Spaide RF, Schumann R, Steel D, Figueroa MS et al (2020) Optical coherence tomography-based consensus definition for lamellar macular hole. Br J Ophthalmol 104(12):1741–1747CrossRef

22.

Compera D, Entchev E, Haritoglou C, Scheler R, Mayer WJ, Wolf A et al (2015) Lamellar hole-associated epiretinal proliferation in comparison to epiretinal membranes of macular pseudoholes. Am J Ophthalmol 160(2):373–384.e1CrossRef

23.

Chehaibou I, Hubschman JP, Kasi S, Su D, Joseph A, Prasad P et al (2021) Spontaneous conversion of lamellar macular holes to full-thickness macular holes: clinical features and surgical outcomes. Ophthalmol Retina 5(10):1009–1016CrossRef

24.

Maier M, Schumann R, Friedrich J, Klaas J, Haritoglou C (2021) Biomarkers in full-thickness and lamellar defects of the macula. Ophthalmologe 118(4):321–336CrossRef

25.

Essex RW, Hunyor AP, Moreno-Betancur M, Yek JTO, Kingston ZS, Campbell WG et al (2018) The visual outcomes of macular hole surgery: a registry-based study by the Australian and new zealand society of retinal specialists. Ophthalmol Retina 2(11):1143–1151CrossRef

26.

Jackson TL, Nicod E, Angelis A, Grimaccia F, Prevost AT, Simpson ARH et al (2013) Pars plana vitrectomy for vitreomacular traction syndrome: a systematic review and metaanalysis of safety and efficacy. Retina 33(10):2012–2017CrossRef

27.

de Bustros S (1994) Vitrectomy for prevention of macular holes. Results of a randomized multicenter clinical trial. Vitrectomy for prevention of macular hole study group. Ophthalmology 101(6):1055–1059 (discussion 1060)

28.

Parolini B, Michalewska Z, Hardin JS, Ducournau D, Othman IS, Faramawi MF et al (2020) European vitreoretinal society macular hole study, prognostic factors for anatomical and functional success. Med Hypothesis Discov Innov Ophthalmol 9(3):198–207CrossRef

29.

Steel DH, Donachie PHJ, Aylward GW, Laidlaw DA, Williamson TH, Yorston D et al (2021) Factors affecting anatomical and visual outcome after macular hole surgery: findings from a large prospective UK cohort. Eye (Lond) 35(1):316–325CrossRef

30.

Paques M, Chastang C, Mathis A, Sahel J, Massin P, Dosquet C et al (1999) Effect of autologous platelet concentrate in surgery for idiopathic macular hole: results of a multicenter, double-masked, randomized trial. Platelets in macular hole surgery group. Ophthalmology 106(5):932–938CrossRef

31.

Michalewska Z, Michalewski J, Adelman RA, Nawrocki J (2010) Inverted internal limiting membrane flap technique for large macular holes. Ophthalmology 117(10):2018–2025CrossRef

32.

Eckardt C, Eckardt U, Groos S, Luciano L, Reale E (1997) Removal of the internal limiting membrane in macular holes. Clinical and morphological findings. Ophthalmologe 94(8):545–551CrossRef

33.

Lois N, Burr J, Norrie J, Vale L, Cook J, McDonald A et al (2011) Internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole: a pragmatic randomized controlled trial. Invest Ophthalmol Vis Sci 52(3):1586–1592CrossRef

34.

Spiteri Cornish K, Lois N, Scott NW, Burr J, Cook J, Boachie C et al (2014) Vitrectomy with internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole. Ophthalmology 121(3):649–655CrossRef

35.

Tadayoni R, Holz FG, Zech C, Liu X, Spera C, Stalmans P (2019) Assessment of anatomical and functional outcomes WITH ocriplasmin treatment IN patients WITH vitreomacular traction WITH or without MacUlar holes: results of Oviid‑1 trial. Retina 39(12):2341–2352CrossRef

36.

Chatziralli IP, Theodossiadis PG, Steel DHW (2018) Internal limiting membrane peeling IN MacUlar hole surgery; WHY, when, and how? Retina 38(5):870–882CrossRef

37.

Modi A, Giridhar A, Gopalakrishnan M (2017) Comparative analysis of outcomes WITH variable diameter internal limiting membrane peeling IN surgery for idiopathic MacUlar hole repair. Retina 37(2):265–273CrossRef

38.

Bae K, Kang SW, Kim JH, Kim SJ, Kim JM, Yoon JM (2016) Extent of internal limiting membrane peeling and its impact on macular hole surgery outcomes: a randomized trial. Am J Ophthalmol 169:179–188CrossRef

39.

Kanda S, Uemura A, Yamashita T, Kita H, Yamakiri K, Sakamoto T (2004) Visual field defects after intravitreous administration of indocyanine green in macular hole surgery. Arch Ophthalmol 122(10):1447–1451CrossRef

40.

Tsuiki E, Fujikawa A, Miyamura N, Yamada K, Mishima K, Kitaoka T (2007) Visual field defects after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 143(4):704–705CrossRef

41.

Rodrigues EB, Meyer CH, Mennel S, Farah ME (2007) Mechanisms of intravitreal toxicity of indocyanine green dye: implications for chromovitrectomy. Retina 27(7):958–970CrossRef

42.

Lindtjørn B, Krohn J, Haugstad M, Stene-Johansen I, Austeng D, Basit S et al (2022) Air versus sulfur hexafluoride gas tamponade for small and medium sized macular holes: a randomized noninferiority trial. Ophthalmol Retina 6(9):828–834CrossRef

43.

Rishi P, Rishi E, Bhende P, Bhende M, Kandle K, Attiku Y et al (2022) A prospective, interventional study comparing the outcomes of macular hole surgery in eyes randomized to C3F8, C2F6, or SF6 gas tamponade. Int Ophthalmol 42(5):1515–1521CrossRef

44.

Modi A, Giridhar A, Gopalakrishnan M (2017) Sulfurhexafluoride (SF6) versus perfluoropropane (C3F8) gas as tamponade IN MacUlar hole surgery. Retina 37(2):283–290CrossRef

45.

Essex RW, Kingston ZS, Moreno-Betancur M, Shadbolt B, Hunyor AP, Campbell WG et al (2016) The effect of postoperative face-down positioning and of long- versus short-acting gas in macular hole surgery: results of a registry-based study. Ophthalmology 123(5):1129–1136CrossRef

46.

Dervenis N, Dervenis P, Sandinha T, Murphy DC, Steel DH (2022) Intraocular tamponade choice with vitrectomy and internal limiting membrane peeling for idiopathic macular hole: a systematic review and meta-analysis. Ophthalmol Retina 6(6):457–468. https://doi.org/10.1016/j.oret.2022.01.023CrossRef

47.

Solebo AL, Lange CA, Bunce C, Bainbridge JW (2011) Face-down positioning or posturing after macular hole surgery. Cochrane Database Syst Rev 12:CD8228

48.

Ye T, Yu JG, Liao L, Liu L, Xia T, Yang LL (2019) Macular hole surgery recovery with and without face-down posturing: a meta-analysis of randomized controlled trials. BMC Ophthalmol 19(1):265CrossRef

49.

Pasu S, Bell L, Zenasni Z, Lanz D, Simmonds IA, Thompson A et al (2020) Facedown positioning following surgery for large full-thickness macular hole: a multicenter randomized clinical trial. JAMA Ophthalmol 138(7):725–730CrossRef

50.

Alberti M, la Cour M (2016) Nonsupine positioning IN MacUlar hole surgery: a noninferiority randomized clinical trial. Retina 36(11):2072–2079CrossRef

51.

Zhang Y, Chen X, Hong L, Yan Y, Zeng M, Huang Z et al (2019) Facedown positioning after vitrectomy WILL not facilitate MacUlar hole closure based on swept-source optical coherence tomography imaging IN gas-filled eyes: a prospective, randomized comparative interventional study. Retina 39(12):2353–2359CrossRef

52.

Jackson TL, Donachie PHJ, Sparrow JM, Johnston RL (2013) United Kingdom national ophthalmology database study of vitreoretinal surgery: report 2, macular hole. Ophthalmology 120(3):629–634CrossRef

53.

Jackson TL, Donachie PHJ, Johnston RL (2016) Vitreomacular traction study group. Electronic medical record database study of vitrectomy and observation for vitreomacular traction. Retina 36(10):1897–1905CrossRef

54.

Stalmans P, Benz MS, Gandorfer A, Kampik A, Girach A, Pakola S et al (2012) Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med 367(7):606–615CrossRef

55.

Khanani AM, Duker JS, Heier JS, Kaiser PK, Joondeph BC, Kozma P et al (2019) Ocriplasmin treatment leads to symptomatic vitreomacular adhesion/vitreomacular traction resolution in the real-world setting: the phase IV orbit study. Ophthalmol Retina 3(1):32–41CrossRef

56.

Steel DHW, Patton N, Stappler T, Karia N, Hoerauf H, Patel N et al (2021) Ocriplasmin for vitreomacular traction IN clinical practice: the inject study. Retina 41(2):266–276CrossRef

57.

Haller JA, Stalmans P, Benz MS, Gandorfer A, Pakola SJ, Girach A et al (2015) Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials. Ophthalmology 122(1):117–122CrossRef

58.

Neffendorf JE, Kirthi V, Pringle E, Jackson TL (2017) Ocriplasmin for symptomatic vitreomacular adhesion. Cochrane Database Syst Rev 10:CD11874

59.

Ha Haynes MRJ, Depla D, de la Cour MD, Lesnik-Oberstein S, Muqit MMK et al (2016) Rhegmatogenous retinal detachment following intravitreal ocriplasmin. Graefes Arch Clin Exp Ophthalmol 254(12):2333–2338CrossRef

60.

Errera MH, Liyanage SE, Petrou P, Keane PA, Moya R, Ezra E et al (2018) A study of the natural history of vitreomacular traction syndrome by OCT. Ophthalmology 125(5):701–707CrossRef

61.

Chan CK, Mein CE, Glassman AR, Beaulieu WT, Calhoun CT, Jaffe GJ et al (2021) Pneumatic vitreolysis with perfluoropropane for vitreomacular traction with and without macular hole: DRCR retina network protocols AG and AH. Ophthalmology 128(11):1592–1603CrossRef

62.

Baumann C, Sabatino F, Zheng Y, Johannigmann-Malek N, Maier M, Kaye SB et al (2022) Anatomical and functional outcomes of pneumatic vitreolysis for treatment of vitreomacular traction with and without macular holes. Graefes Arch Clin Exp Ophthalmol 260(7):2209–2215. https://doi.org/10.1007/s00417-022-05568-yCrossRef

63.

Fallico M, Jackson TL, Chronopoulos A, Hattenbach LO, Longo A, Bonfiglio V et al (2021) Factors predicting normal visual acuity following anatomically successful macular hole surgery. Acta Ophthalmol 99(3):e324–9CrossRef

64.

Tognetto D, Grandin R, Sanguinetti G, Minutola D, Di Nicola M, Di Mascio R et al (2006) Internal limiting membrane removal during macular hole surgery: results of a multicenter retrospective study. Ophthalmology 113(8):1401–1410CrossRef

65.

Vereinigung Deutscher Ophthalmologischer Chefärzte (DOCH), Retinologische Gesellschaft (RG), Vereinigung Ophthalmologischer Lehrstuhlinhaber (VOL), Deutsche Ophthalmologische Gesellschaft (DOG) (2020) Krisenplan ophthalmologische nicht-elektive Basisversorgung in bettenführenden Kliniken. https://www.dog.org/wp-content/uploads/2020/03/Ophthalmologische-Basisversorgung_Krisenplan-DOCH_VOL_DOG_RG_31-03-20_Update-2.pdf. Zugegriffen: 7. Aug. 2022

66.

Garg A, Ballios BG, Yan P (2022) Spontaneous closure of an idiopathic full-thickness macular hole: a literature review. J Vit Ret Dis 6(5):381–390

67.

Berton M, Robins J, Frigo AC, Wong R (2020) Rate of progression of idiopathic full-thickness macular holes before surgery. Eye (Lond) 34(8):1386–1391CrossRef

68.

Maguire MJ, Steel DH, Yorston D, Hind J, El-Faouri M, Jalil A et al (2021) Outcome of revision procedures for failed primary MacUlar hole surgery. Retina 41(7):1389–1395CrossRef

69.

Szurman P, Wakili P, Stanzel BV, Siegel R, Boden KT, Rickmann A (2021) Persistent macular holes—what is the best strategy for revision? Graefes Arch Clin Exp Ophthalmol 259(7):1781–1790CrossRef

70.

Caporossi T, Tartaro R, Finocchio L, Pacini B, De Angelis L, Bacherini D et al (2021) Human amniotic membrane to treat MacUlar holes that failed to close, sulfur hexafluoride endotamponade versus air endotamponade: a prospective comparative study. Retina 41(4):735–743CrossRef

71.

Peng J, Chen C, Zhang H, Zhang L, Liu J, Ren J et al (2021) Long-term surgical outcomes of lens capsular flap transplantation IN the management of refractory MacUlar hole. Retina 41(4):726–734CrossRef

72.

Moysidis SN, Koulisis N, Adrean SD, Charles S, Chetty N, Chhablani JK et al (2021) Autologous retinal transplantation for primary and refractory macular holes and macular hole retinal detachments: the global consortium. Ophthalmology 128(5):672–685CrossRef

73.

Schaub F, Gözlügöl N, von Goscinski C, Enders P, Heindl LM, Dahlke C (2021) Outcome of autologous platelet concentrate and gas tamponade compared to heavy silicone oil tamponade in persistent macular hole surgery. Eur J Ophthalmol 31(2):664–672CrossRef

74.

Figueroa MS, Mora Cantallops A, Virgili G, Govetto A (2021) Long-term results of autologous plasma as adjuvant to pars plana vitrectomy in the treatment of high myopic full-thickness macular holes. Eur J Ophthalmol 31(5):2612–2620CrossRef

75.

Felfeli T, Mandelcorn ED (2019) MacUlar hole hydrodissection: surgical technique for the treatment of persistent, chronic, and large macular holes. Retina 39(4):743–752CrossRef

76.

Meyer CH, Szurman P, Haritoglou C, Maier M, Wolf A, Lytvynchuk L et al (2020) Application of subretinal fluid to close refractory full thickness macular holes: treatment strategies and primary outcome: Apostel study. Graefes Arch Clin Exp Ophthalmol 258(10):2151–2161CrossRef

77.

Rizzo S, Genovesi-Ebert F, Vento A, Cresti F, Miniaci S, Romagnoli MC (2009) Heavy silicone oil (densiron-68) for the treatment of persistent macular holes: densiron-68 endotamponade for persistent macular holes. Graefes Arch Clin Exp Ophthalmol 247(11):1471–1476CrossRef

78.

Lappas A, Foerster AMH, Kirchhof B (2009) Use of heavy silicone oil (densiron-68) in the treatment of persistent macular holes. Acta Ophthalmol 87(8):866–870CrossRef

79.

Li JQ, Brinken R, Holz FG, Krohne TU (2021) Silicone oil tamponade for persistent macular holes. Eye (Lond) 35(8):2206–2212CrossRef

Titel: Makulaforamen und vitreomakuläre Traktion
S1-Leitlinie der Deutschen Ophthalmologischen Gesellschaft (DOG), der Retinologischen Gesellschaft (RG) und des Berufsverbands der Augenärzte Deutschlands (BVA). Version: 22. September 2022
verfasst von: Deutsche Ophthalmologische Gesellschaft e. V. (DOG)
Retinologische Gesellschaft e. V. (RG)
Berufsverband der Augenärzte Deutschlands e. V. (BVA)
Publikationsdatum: 13.12.2022
Verlag: Springer Medizin
Schlagwörter: Peeling
Vitrektomie
Erschienen in: Die Ophthalmologie / Ausgabe Sonderheft 1/2023
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI: https://doi.org/10.1007/s00347-022-01774-5

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Makulaforamen und vitreomakuläre Traktion

S1-Leitlinie der Deutschen Ophthalmologischen Gesellschaft (DOG), der Retinologischen Gesellschaft (RG) und des Berufsverbands der Augenärzte Deutschlands (BVA). Version: 22. September 2022

Auszug

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde

Springer Medizin

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 1/2023

Web-based gene expression analysis—paving the way to decode healthy and diseased ocular tissue

Risikofaktoren und Prophylaxe der rhegmatogenen Netzhautablösung bei Erwachsenen

Erbliche Netzhaut‑, Aderhaut- und Sehbahnerkrankungen

Erratum zu: Erste klinische Ergebnisse mit dem PAUL®-Glaukom-Implantat an der Universitäts-Augenklinik Bonn

Erratum zu: Therapierefraktäre Epiphora nach Dakryozystorhinostomie – Stellenwert von Bildgebung und Histopathologie

Erratum zu: Jenseits von Ästhetik – Regenerative Medizin bei schweren Erkrankungen der okulären Adnexe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde